Jiangsu Yabang Pharmaceutical Logistics Centre

Investment decisions ultimately trace to Xu Xiaochu, the founder and chairman of Yabang Investment Holding Group. Public filings for the group's listed subsidiary show that family members, including his daughter Xu Yajuan, hold executive roles, suggesting investment authority remains closely held within the family office structure rather than delegated to an external investment committee.

The wealth originates from specialty chemicals and dyestuff manufacturing. Xu Xiaochu founded the Yabang group around this industrial base, and his prior appearance on the Hurun Rich List confirms the liquidity generated by these operations. The group has since diversified into pharmaceuticals, logistics, and solar manufacturing, each contributing to the pool of capital the Centre deploys.

It operates as a hybrid. Structurally, it is a corporate investor sitting within an industrial conglomerate, but it functions like a single family office because Xu Xiaochu controls the parent group and the investment vehicle. Unlike a standard corporate venture capital unit answering to public shareholders, the Centre deploys capital from family-controlled operating entities.

No explicit sector exclusions are publicly stated. The disclosed investment footprint concentrates on pharmaceutical logistics, industrial real estate, and renewable energy joint ventures, suggesting the Centre prefers sectors adjacent to its parent group's operating expertise. There is no evidence of investment in consumer internet, financial services, or other sectors far removed from the industrial core.

Yes, the Yabang Millions of Glory Fund is the group's philanthropic vehicle. There is limited public disclosure on its grant-making focus or separation from the investment entity, but its existence confirms the family maintains a formal philanthropic structure alongside its investment activities.